Table 1.
Region | Gene | Saline | Cisplatin |
---|---|---|---|
24h post-treatment | |||
Hippocampus | IL-1β | 1.00 (0.10) | 0.75 (0.05)* |
IL-6 | 1.00 (0.12) | 1.15 (0.11) | |
TNFα | 1.00 (0.13) | 0.80 (0.08) | |
GFAP | 1.00 (0.06) | 0.87 (0.03)* | |
CD11b | 1.00 (0.05) | 0.86 (0.04)* | |
Prefrontal Cortex |
IL-1β | 1.00 (0.16) | 0.97 (0.09) |
IL-6 | 1.00 (0.06) | 0.91 (0.07) | |
TNFα | 1.00 (0.37) | 0.73 (0.11) | |
GFAP | 1.00 (0.06) | 0.81 (0.01)* | |
CD11b | 1.00 (0.05) | 0.80 (0.17) | |
7d post-treatment | |||
Hippocampus | IL-1β | 1.00 (0.22) | 1.06 (0.25) |
IL-6 | 1.00 (0.30) | 1.44 (0.28) | |
TNFα | 1.00 (0.07) | 0.76 (0.05)* | |
GFAP | 1.00 (0.10) | 1.03 (0.14) | |
CD11b | 1.00 (0.15) | 1.03 (0.14) | |
Prefrontal Cortex |
IL-1β | 1.00 (0.08) | 0.88 (0.13) |
IL-6 | 1.00 (0.13) | 1.15 (0.06) | |
TNFα | 1.00 (0.18) | 1.07 (0.30) | |
GFAP | 1.00 (0.03) | 1.20 (0.24) | |
CD11b | 1.00 (0.04) | 1.02 (0.10) |